CA2663941A1 — Stabilized solid forms and method for the production thereof
Assigned to Losan Pharma GmbH · Expires 2008-04-03 · 18y expired
What this patent protects
The invention relates to solid medicinal forms containing at least one ac tive ingredient and at least one pharmaceutically compatible, water-soluble drying agent that is selected from the group consisting of trimagnesium dici trate and/or calcium chloride. The solid medicinal fo…
USPTO Abstract
The invention relates to solid medicinal forms containing at least one ac tive ingredient and at least one pharmaceutically compatible, water-soluble drying agent that is selected from the group consisting of trimagnesium dici trate and/or calcium chloride. The solid medicinal form has a maximum drying loss of 6% and a relative equilibrium moisture content of 25% or less. The invention also relates to solid medicinal forms containing a moisture-sensit ive active ingredient and trimagnesium dicitrate.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.